IL17 Cancer Research Results
IL17, Interleukin-17: Click to Expand ⟱
| Source: |
| Type: |
Also known as IL-17A.
Interleukin-17A is a protein that in humans is encoded by the IL17A gene.
Higher levels of serum IL-17 are associated with poor prognosis for a variety of solid tumors in cancer patients.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*other↝, *other↝, *CRP↓, *eff↝, *other↑, *CXCR4↓, *IL1β↓, *IL6↓, *IL17↓, *IL18↓, *TNF-α↓, *MMP9↓, *PGE2↓, *COX1↓, *COX2↓, *PI3K↓, *Akt↓, *other↑, TumCCA↑, Apoptosis↑, ROS↑, JNK↑, TumAuto↑, Hif1a↓, BNIP3↝, HSP90↓, Fas↑, FasL↑, ETC↓, VEGF↓, angioG↓, RadioS↑, *neuroP↑, *HSP70/HSPA5↑, *ROS↓, *MMP↑, *Cyt‑c↓, *Casp3↓, *Casp9↓, *MAPK↓, *Dose⇅, *HSPs↑, BioAv↓, Dose↝,
| - |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *ROS↓, *Inflam↓, *Apoptosis↓, *IL1β↓, *TNF-α↓, *COX2↓, *iNOS↓, *NF-kB↓, *JNK↓, *HDAC↓, *GSK‐3β↓, *IFN-γ↓, *IL17↓, *GSH↑, *NRF2↑, *HO-1↑, *SOD↑, *MDA↓, *NO↓, *GPx↑, *TBARS↓, *AChE↓, *GR↑, *Catalase↑, *VitC↑, *memory↑, *lipid-P↓, *ROS↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ETC↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, Fas↑, 1, FasL↑, 1, JNK↑, 1,
Protein Folding & ER Stress ⓘ
HSP90↓, 1,
Autophagy & Lysosomes ⓘ
BNIP3↝, 1, TumAuto↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, Dose↝, 1, RadioS↑, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GPx↑, 1, GSH↑, 1, HO-1↑, 1, lipid-P↓, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 3, SOD↑, 1, TBARS↓, 1, VitC↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, iNOS↓, 1, JNK↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other↑, 2, other↝, 2,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1, HSPs↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 1, HDAC↓, 1, PI3K↓, 1,
Migration ⓘ
MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 2, CRP↓, 1, CXCR4↓, 1, IFN-γ↓, 1, IL17↓, 2, IL18↓, 1, IL1β↓, 2, IL6↓, 1, Inflam↓, 1, NF-kB↓, 1, PGE2↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission ⓘ
AChE↓, 1,
Hormonal & Nuclear Receptors ⓘ
GR↑, 1,
Drug Metabolism & Resistance ⓘ
Dose⇅, 1, eff↝, 1,
Clinical Biomarkers ⓘ
CRP↓, 1, IL6↓, 1,
Functional Outcomes ⓘ
memory↑, 1, neuroP↑, 2,
Total Targets: 50
Scientific Paper Hit Count for: IL17, Interleukin-17
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:540 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page